Nobiletin, a hexamethoxyflavone, inhibits the EMT process initiated by hypoxia in renal cell carcinoma via the NF-κB and the Wnt/β-signaling pathways, dampening cancer migration and invasion (malignancy) [166]. Here, NFKB1 is linked to cancer.